References
- Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, Ishikawa S, Shimada K. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens 2004; 17: 112–117, [INFOTRIEVE], [CSA]
- Opie LH, Yasuf S, Küber W. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Prog Cardiovasc Dis 2000; 43: 171–196, [INFOTRIEVE], [CSA], [CROSSREF]
- Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 1987; 75: 1110–1116, [INFOTRIEVE], [CSA]
- Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326–1331, [INFOTRIEVE], [CSA]
- Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 2004; 109(Suppl.2)II-27–II-33, [CSA], [CROSSREF]
- Sakai K, Hirooka Y, Matsuo I, Eshima K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 2000; 36: 1023–1028, [INFOTRIEVE], [CSA]
- Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, Takeshita A. Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 2002; 39: 264–268, [INFOTRIEVE], [CSA], [CROSSREF]
- Oizumi K, Nishino H, Koike H. Antihypertensive effects of CS-905, a novel dihydropyridine calcium channel blocker in conscious hypertensive dogs. Jpn J Pharmacol 1990; 53: 264–266, [INFOTRIEVE], [CSA]
- Oizumi K, Nishino H, Miyake S, Shiga H, Sada T, Miyamoto M, Koike H. Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium channel blocker, in conscious SHR. Jpn J Pharmacol 1990; 54: 1–6, [INFOTRIEVE], [CSA]
- Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, Kimura T. Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker. Jpn J Pharmacol 1989; 51: 57–64, [INFOTRIEVE], [CSA]
- Kuramoto K, Ichikawa S, Hirai A, Kanada S, Nakachi T, Ogihara T. Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res 2003; 26: 201–208, [INFOTRIEVE], [CSA], [CROSSREF]
- Arita M, Hashizume T, Tanigawa K, Yamamoto H, Nishio I. A new Ca-antagonist, azelnidipine, reduced blood pressure during exercise without augmentation of sympathetic nervous system in essential hypertension: a randomized, double-blind, placebo-controlled trial. J Cardiovasc Pharmacol 1999; 33: 186–192, [INFOTRIEVE], [CSA], [CROSSREF]
- Kobayashi N, Kobayashi K, Hara K, Higashi T, Yanaka H, Yagi S, Matsuoka H. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Am J Hypertens 1999; 12: 483–491, [INFOTRIEVE], [CSA], [CROSSREF]
- Tabrizchi R. Amlodipine and endothelial nitric oxide synthase activity. Cardiovasc Res 2003; 59: 807–809, [INFOTRIEVE], [CSA], [CROSSREF]
- Berkels R, Taubert D, Bartels H, Breitenbach TB. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2004; 70: 39–45, [INFOTRIEVE], [CSA], [CROSSREF]
- Lenasi H, Kohlstedt K, Fichtlscherer B, Mülsch A, Busse R, Fleming I. Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495. Cardiovasc Res 2003; 59: 844–853, [INFOTRIEVE], [CSA], [CROSSREF]
- Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 2003; 55: 271–324, [INFOTRIEVE], [CSA], [CROSSREF]
- Huang BS, Leenen FHH. Sympathoinhibitory effects of central nifedipine in spontaneously hypertensive rats on high versus regular sodium intake. Hypertension 1999; 33: 32–35, [INFOTRIEVE], [CSA]
- Huang BS, Murzenok PP, Leenen FHH. Sympathoinhibitory and depressor responses to long-term infusion of nifedipine in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2000; 36: 704–710, [INFOTRIEVE], [CSA], [CROSSREF]
- Murzenok PP, Huang BS, Leenen FHH. Sympathoinhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension 2000; 35: 631–636, [INFOTRIEVE], [CSA]
- Huang BS, Leenen FHH. Sympathoinhibitory and depressor effects of amlodipine in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2003; 42: 153–160, [INFOTRIEVE], [CSA], [CROSSREF]
- Soong TW, Stea A, Hodson CD, Dubel SJ, Vincent SR, Snutch TP. Structure and functional expression of a member of the low voltage-activated calcium channel family. Science 1993; 260: 1133–1136, [INFOTRIEVE], [CSA], [CROSSREF]
- Miller RJ. Multiple calcium channels and neuronal function. Science 1987; 235: 46–52, [INFOTRIEVE], [CSA], [CROSSREF]
- Higuchi S, Takeshita A, Ito N, Imaizumi T, Matsuguchi H, Nakamura M. Arterial pressure and heart rate responses to calcium channel blockers administered in the brain stem in rats. Circ Res 1985; 57: 244–251, [INFOTRIEVE], [CSA]
- Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A. Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. J Hypertens 2003; 21: 379–386, [INFOTRIEVE], [CSA], [CROSSREF]
- Binggeli C, Corti R, Sudano I, Luscher TF, Noll G. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension 2002; 39: 892–896, [INFOTRIEVE], [CSA], [CROSSREF]